Trials / Terminated
TerminatedNCT03871309
Tigertriever Distal Vessels Registry
- Status
- Terminated
- Phase
- —
- Study type
- Observational
- Enrollment
- 9 (actual)
- Sponsor
- Rapid Medical · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
A registry study to collect data on the Tigertriever device at restoring blood flow by removing clots in M2 or distal vessels in patients experiencing acute ischemic stroke, during commercial use.
Detailed description
Tigertriever is a CE marked mechanical revascularization device indicated to restore blood flow by removing thrombus from a large intracranial vessel in patients experiencing ischemic stroke within 8 hours of symptom onset.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Tigertriever | Mechanical Thrombectomy |
Timeline
- Start date
- 2020-02-07
- Primary completion
- 2022-08-04
- Completion
- 2023-10-10
- First posted
- 2019-03-12
- Last updated
- 2024-04-12
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03871309. Inclusion in this directory is not an endorsement.